| Leo J Fontana, MD | |
|
1500 Saint Georges Ave, Avenel, NJ 07001-1000 | |
| (732) 381-8686 | |
| (732) 499-7724 |
| Full Name | Leo J Fontana |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 33 Years |
| Location | 1500 Saint Georges Ave, Avenel, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194722637 | NPI | - | NPPES |
| 7103506 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 25MA05939000 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayshore Medical Center | Holmdel, NJ | Hospital |
| Jfk Medical Center | Edison, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Imaging Llc | 8123312055 | 47 |
| Health Village Imaging Llc | 9537263223 | 23 |
| The New Jersey Imaging Network, Llc | 2860633492 | 64 |
News Archive
Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
The molecular missteps that disrupt brain function in the most common form of adult-onset muscular dystrophy have been revealed in a new study published by Cell Press. Myotonic dystrophy is marked by progressive muscle wasting and weakness, as well as excessive daytime sleepiness, memory problems, and mental retardation.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 1 days ago
| Entity Name | Avenel Iselin Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487674867 PECOS PAC ID: 5597751941 Enrollment ID: O20040422000098 |
News Archive
Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
The molecular missteps that disrupt brain function in the most common form of adult-onset muscular dystrophy have been revealed in a new study published by Cell Press. Myotonic dystrophy is marked by progressive muscle wasting and weakness, as well as excessive daytime sleepiness, memory problems, and mental retardation.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 1 days ago
| Entity Name | Englewood Radiologic Group P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639136914 PECOS PAC ID: 6901852300 Enrollment ID: O20050329000957 |
News Archive
Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
The molecular missteps that disrupt brain function in the most common form of adult-onset muscular dystrophy have been revealed in a new study published by Cell Press. Myotonic dystrophy is marked by progressive muscle wasting and weakness, as well as excessive daytime sleepiness, memory problems, and mental retardation.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 1 days ago
| Entity Name | Health Village Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194810978 PECOS PAC ID: 9537263223 Enrollment ID: O20070406000359 |
News Archive
Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
The molecular missteps that disrupt brain function in the most common form of adult-onset muscular dystrophy have been revealed in a new study published by Cell Press. Myotonic dystrophy is marked by progressive muscle wasting and weakness, as well as excessive daytime sleepiness, memory problems, and mental retardation.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 1 days ago
| Entity Name | The New Jersey Imaging Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629327887 PECOS PAC ID: 2860633492 Enrollment ID: O20130724000791 |
News Archive
Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
The molecular missteps that disrupt brain function in the most common form of adult-onset muscular dystrophy have been revealed in a new study published by Cell Press. Myotonic dystrophy is marked by progressive muscle wasting and weakness, as well as excessive daytime sleepiness, memory problems, and mental retardation.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 1 days ago
| Entity Name | Coastal Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710334727 PECOS PAC ID: 8123312055 Enrollment ID: O20160816000083 |
News Archive
Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
The molecular missteps that disrupt brain function in the most common form of adult-onset muscular dystrophy have been revealed in a new study published by Cell Press. Myotonic dystrophy is marked by progressive muscle wasting and weakness, as well as excessive daytime sleepiness, memory problems, and mental retardation.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leo J Fontana, MD 1500 Saint Georges Ave, Avenel, NJ 07001-1000 Ph: (732) 381-8686 | Leo J Fontana, MD 1500 Saint Georges Ave, Avenel, NJ 07001-1000 Ph: (732) 381-8686 |
News Archive
Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
The molecular missteps that disrupt brain function in the most common form of adult-onset muscular dystrophy have been revealed in a new study published by Cell Press. Myotonic dystrophy is marked by progressive muscle wasting and weakness, as well as excessive daytime sleepiness, memory problems, and mental retardation.
Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.
Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 1 days ago
Edward S Rittweger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
David G Wirtshafter, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Mark Singer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Charles A Saniewski, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Dr. Peter S Doss, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-574-8999 Fax: 732-574-3488 | |
Robert Bashkim Limani, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 |